Co-existent de novo myelodysplastic syndrome and T-cell non-Hodgkin lymphoma: A common origin or not?

Journal of International Medical Research

Volumn 37, Issue 1, 2009, Pages 270-276

  Huang, H H ^a   Zhu, J Y ^a   Han, J Y ^a   Shen, L J ^a   Xu, L ^a   Chen, X L ^a   Zheng, L Y ^a   Chen, Fang Yuan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Co existence; Myelodysplastic syndrome; Non Hodgkin lymphoma; T cell

Indexed keywords

ARSENIC ACID; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; MESNA; MITOXANTRONE; PREDNISONE; TENIPOSIDE; THALIDOMIDE; VINCRISTINE;

ADULT; ARTICLE; BONE MARROW BIOPSY; CANCER CHEMOTHERAPY; CASE REPORT; CHROMOSOME 20Q; CHROMOSOME DELETION; CLINICAL FEATURE; COMORBIDITY; CYTOPENIA; DYSPLASIA; HISTOPATHOLOGY; HUMAN; LYMPH NODE BIOPSY; MALE; MYELODYSPLASTIC SYNDROME; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; T CELL LYMPHOMA; MIDDLE AGED;

HUMANS; LYMPHOMA, T-CELL; MALE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES;

EID: 64149117042     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000903700134     Document Type: Article

References (29)

1. Kantarjian HM, Keating MJ, Walters RS, et al: Therapy-related leukemia and myelodysplastic syndrome: clinical, cytogenetic, and prognostic feature. J Clin Oncol 1986: 4: 1748-1757.
2. Jaffe ES, Harris NL, Stein H, et al (eds): WHO Classification of Tumours: Tumours of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001.
3. Sans-Sabrafen J, Buxo-Costa J, Woessner S, et al: Myelodysplastic syndromes, and malignant solid tumors: analysis of 21 cases. Am J Hematol 1992; 41: 1-4.
4. Abruzzese E, Buss D, Rainer R, et al: Progression of a myelodysplastic syndrome to pre-B lymphoblastic leukemia. A case report and cell lineage study. Ann Hematol 1996; 73: 35-38.
5. Copplestone JA, Mufti GJ, Hamblin TJ, et al: Immunologic abnormalities in myelodysplastic syndromes II. Coexistent lymphoid or plasma cell neoplasms. A report of 20 cases unrelated to chemotherapy. Br J Haematol 1986; 63: 149-159.
6. Florensa L, Vallespi T, Woessner S, et al: Incidence and characteristics of lymphoid malignancies in untreated myelodysplastic syndromes. Leuk Lymphoma 1996; 23: 609-612.
7. Hamblin TJ: Immunologic abnormalities in myelodysplastic syndromes. Semin Hematol 1996; 3: 150-162.
8. Anzai T., Hirose W, Nakane H, et al: Myelodysplastic syndrome associated with immunoblastic lymphadenopathy-like T-cell lymphoma: simultaneous clinical improvement with chemotherapy. Jpn J Clin Oncol 1994; 24: 106-110.
9. Uematsu M, Ochi H, Ueda Y, et al: Coexistent myelodysplastic syndrome and non-Hodgkin's lymphoma. Report of a case and review of the literature. Int J Hematol 1995; 62: 45-51.
10. Takoku T, Miyazawa K, Sashida G, et al: Hepatosplenic αβ T-cell lymphoma with myelodysplastic syndrome. Int J Hematol 2005; 82: 143-147.
11. Xu B., Meng FY, Li YQ: T-cell non-Hodgkin lymphoma with myelodysplastic syndrome: A case report. Zhonghua Zhong Liu Za Zhi 2005; 27: 320.
12. Sato T, Shiga Y, Takeda H, et al: IBL-like T-cell lymphoma with helper T-cell phenotype in a case of myelodysplastic syndrome. Rinsho Ketsueki 1986; 27: 612-616.
13. Auger MJ, Nash JRG, Mackie MJ, et al: Marrow involvement with T cell lymphoma initially presenting as abnormal myelopoiesis. J Clin Pathol 1986; 39: 134-137.
14. Kawashima K, Furukawa Y, Akutu M, et al: Primary non-Hodgkin's lymphoma; small lymphocytic type, in the spleen complicating myelodysplastic syndrom. J Jpn Soc Intern Med 1988; 77: 1051-1055.
15. Breccia M, Petti MC, D'Elia GM, et al: Cutaneous pleomorphic T-cell lymphoma coexisting with myelodysplastic syndrome transforming into acute myeloid leukemia: Successful treatment with a fludarabine-containing regimen. Eur J Haematol 2002; 68: 1-3.
16. Dalamaga M, Karmaniolas K, Chavelas C, et al: Coexistence of primary refractory anemia with ringed sideroblasts and T cell lymphoblastic non-Hodgkin lymphoma. Acta Haematol 2004; 111: 171-172.
17. Cheng HB, Luo MZ, Zhang SM: A case of acute myelomonocytic leukemia transfonned from myelodysplastic syndrome coincident with malignant lymphoma. Mod Diagn Treat 2004; 15: 191.
18. Liu GX, Li X: Coexistence of myelodysplastic syndrome and malignant lymphoma in the peritoneal cavity: a case report. Henan Zhong Liu Xue Za Zhi 2001; 14: 172.
19. Rostoker G, Raphael M, Boisnick S, et al: Coexistence of Sézary syndrome and dysmyelopoiesis with an excess of myeloblasts. J Am Acad Dermatol 1996; 15: 1296-1298.
20. Kazakov DV, Mentzel T, Burg G, et al: Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: A coincidence or more? Br J Dermatol 2003; 149: 869-876.
21. Clark RE, Payne HE, Jacobs A, et al: Primary myelodysplastic and cancer. Br Med J (Clin Res 'Ed) 1987; 294: 937-938.
22. Tefferi A, Thibodeau SN, Sorberg LA, et al: Clonal studies in the myelodysplastic syndrome using X-linked restriction fragment length polymorphisms. Blood 1990; 75: 1770-1773.
23. Weimar IS, Bourhis JH, De Gast GC, et al: Clonality in myelodysplastic syndrome. Leuk Lymphoma 1994; 13: 215-221.
24. Brezinová J, Zemanová Z, Ransdorfová S, et al: Prognostic significance of del(20q) in patients with hematological malignancies. Cancer Genet Cytogenet 2005; 160: 188-192.
25. Qin L, Wang C., Qin YW, et al: Distribution of abnormal cell clone with deletion of chromosome 20q in marrow cell lineages and apopto cells in myelodysplastic syndrome. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2008; 16: 551-554.
26. Bynoe AG, Scott, CS, Ford P, et al: Decreased T helper cells in the myelodysplastic syndromes. Br J Haematol 1983; 54: 97-102.
27. Colombat PH, Renoux M, Lamagnere JO, et al: Immunologic indices in myelodysplastic syndromes. Cancer 1988; 61: 1075-1081.
28. Shimamoto T, Hayashi S, Ando K, et al: Anaplastic large-cell lymphoma which showed severe inflammatory status and myelodysplasia with increased VEGF and IL-6 serum levels after long-term immuno-suppressive therapy. Ann k Hematol 2001; 66: 49-52.
29. Fong GH, Rossant J, Gertsenstein M, et al: Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vaseular endothelium. Nature 1995; 376: 66-70.